Due to ongoing inflationary pressures, the costs of expanding, banking, qualifying and distributing EBiSC iPSCs have increased significantly. As a not-for-profit scientific resource operated by institutions in the UK and Germany, we take our responsibilities towards the long-term safeguarding and sharing of deposited iPSCs very seriously and so must ensure that EBiSC is viable and sustainable long-term.
We have worked to cover as much of these additional costs as we can, however to sustain our operations and to maintain the quality of the resource, a small price adjustment is necessary.
From 1st June onwards, the fee to access vials of EBiSC iPSCs will increase by 3%. This takes into consideration inflation rates both in the United Kingdom and across Europe and will support EBiSC’s longevity and sustainability.
We remain committed to supporting iPSC researchers worldwide through the collection, biobanking and distribution of iPSC lines at defined standards, enabling the re-use of iPS cells and data and positively impacting the efficiency and reproducibility of iPSC research. Thank you for your support!